Supplemental material
Drug Delivery
Volume 24, 2017 - Issue 1
Related Research Data
Intracellular Delivery of ERBB2 siRNA and p53 Gene Synergistically Inhibits the Growth of Established Tumor in an Immunocompetent Mouse
Source:
OMICS Publishing Group
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
Source:
Proceedings of the National Academy of Sciences
English
Source:
Open Access Publishing London
The IGF axis and programmed cell death.
Source:
Wiley
Corrigendum: Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
Source:
Springer Science and Business Media LLC
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.
Source:
Elsevier BV
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.
Source:
Springer Science and Business Media LLC
Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen
Source:
Springer Science and Business Media LLC
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.
Source:
MDPI AG
erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells
Source:
American Association for the Advancement of Science (AAAS)
Sequence-specific inhibition of small RNA function
Source:
Public Library of Science (PLoS)
Methotrexate- and Cyclophosphamide-embedded Pure and Strontiumsubstituted Carbonate Apatite Nanoparticles for Augmentation of Chemotherapeutic Activities in Breast Cancer Cells
Source:
Bentham Science Publishers Ltd.
The insulin-like growth factor system as a treatment target in breast cancer
Source:
Elsevier BV
Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC
Source:
Oxford University Press (OUP)
Biology of HER2 and Its Importance in Breast Cancer
Source:
S. Karger AG
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer.
Source:
Elsevier BV
A new paradigm for cancer therapy
Source:
Wiley
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer
Source:
Bioscientifica
BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF
Source:
Springer Science and Business Media LLC
A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop.
Source:
Rockefeller University Press
Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells.
Source:
American Association for Cancer Research (AACR)
Linking provided by
